Pancreatic cancer care involves a comprehensive, multidisciplinary approach focused on managing the disease and improving the patient’s quality of life. Treatment options depend on the stage of the cancer, the patient’s overall health, and the location of the tumor within the pancreas.
For early-stage pancreatic cancer, surgery is often the primary treatment. The most common procedure is the Whipple procedure, which involves removing the head of the pancreas, parts of the small intestine, bile duct, and sometimes part of the stomach. In cases where the tumor is located in other parts of the pancreas, partial or complete removal of the pancreas may be required.
Chemotherapy and radiation therapy are commonly used alongside surgery, either to shrink the tumor before surgery (neoadjuvant therapy) or to eliminate remaining cancer cells afterward (adjuvant therapy). Chemotherapy may also be the main treatment option for advanced or metastatic pancreatic cancer, where surgery is not feasible.
Targeted therapies and immunotherapy offer newer treatment options for some patients, focusing on specific genetic mutations or boosting the immune system’s ability to fight cancer. These therapies are especially helpful for patients who may not respond to traditional treatments.
For patients with advanced pancreatic cancer, palliative care is essential to manage symptoms such as pain, digestive issues, and weight loss. This care aims to enhance quality of life and manage discomfort.
Since pancreatic cancer is often diagnosed at an advanced stage, early detection remains challenging, but ongoing research is working to improve diagnostic tools and treatment outcomes. Regular follow-ups and personalized treatment plans are crucial for managing this aggressive cancer.